BEAM vs. 90-Yttrium Ibritumomab Tiuxetan (Zevalin®)/BEAM With ASCT for Relapsed DLBCL
Clinical trial NCT02366663 · TERMINATED
Trial details
- NCT number
- NCT02366663
- Sponsor
- City of Hope Medical Center
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-01-01
- Primary completion
- 2016-10-01
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.